UNSPSC 85814117: Introduction of low-dose interleukin-2 into epidural space, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of low-dose interleukin-2 into epidural space, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0S303

UNSPSC 85814117 Introduction of low-dose interleukin-2 into epidural space, percutaneous approach is a Commodity code that shows minimal alignment with state and local procurement activity. The code describes a specific invasive clinical procedure—epidural injection of a targeted immunomodulatory agent—yet the recent state and local opportunities tagged under this code encompass virtual urgent care services, occupational health programs, cancer screening and registry services, employee wellness platforms, behavioral health treatment, opioid recovery initiatives, and inpatient facility operations. These opportunities span telehealth delivery, occupational medicine, specialty clinical services, and behavioral health infrastructure rather than the interventional pain management or neuroimmunological procedure the code nominally describes.

The recent opportunities show issuing bodies across diverse public jurisdictions: Inland Empire Health Plan (California), DeKalb County (Georgia), Nevada Health Authority, San Mateo County (California), Sarasota County (Florida), Boulder County (Colorado), Cobb County (Georgia), City of Ocala (Florida), County of Santa Clara (California), Brevard County (Florida), Fairfax County (Virginia), and multiple Texas agencies. Geographic concentration appears across California, Georgia, Florida, Colorado, and Texas, with scattered activity in Kansas, Nevada, Missouri, and elsewhere. Representative solicitations include Inland Empire Health Plan's RFI for Virtual Urgent Care Services (due October 31, 2026) to deliver 24/7/365 telehealth-based evaluation and management through California board-certified physicians; San Mateo Medical Center's RFP for Cancer Registry Services (due October 12, 2026) to support casefinding and tumor registry workflows at an acute-care hospital and clinic system; and the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly operations (due December 10, 2026) across defined service areas serving Medicare and Medicaid-eligible seniors. The code exhibits no identifiable recent state and local procurement activity for the epidural interleukin-2 procedure it nominally describes; the mismatch between code definition and recent solicitation content suggests either miscoding in source records or that this Commodity sits outside active state and local procurement channels.